Changes in fatalities due to overdose of anxiolytic and sedative drugs in the UK (1983-1999).
OBJECTIVE
To establish the frequency with which anxiolytic and sedative drugs result in fatal poisonings and to examine longitudinal changes in poisoning deaths.


METHODS
The number of fatal poisonings between 1983 and 1999 in England, Scotland and Wales due to a single anxiolytic or sedative drug was obtained from the Department of Health in the UK. This was divided by the number of prescriptions for these drugs in England and Scotland to derive a fatal toxicity index (FTI) of deaths per million prescriptions.


RESULTS
Chloral hydrate, clomethiazole, barbiturates, and related sedatives had much higher FTIs than benzodiazepines, buspirone, zolpidem and zopiclone. There has been a substantial reduction in the annual number of deaths from sedative drug poisoning between 1983 and 1999. This has been due to a sustained reduction in prescriptions for high toxicity drugs and more recently a major reduction in temazepam deaths that coincided with the withdrawal of gelatin capsule formulations.


CONCLUSIONS
Deaths would be expected to be further reduced if there were reduced prescriptions of high toxicity drugs--and the continuing need for short-acting barbiturates, clomethiazole and chloral hydrate should be questioned.
Buckley
Nicholas A
NA
Australian National University Medical School, Canberra, Australian Capital Territory, Australia. nick.buckley@act.gov.au
McManus
Peter R
PR
D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000145:classification / Q000506:poisoning*; D001463:Barbiturates / Q000008:administration & dosage / Q000506:poisoning; D001569:Benzodiazepines / Q000008:administration & dosage / Q000506:poisoning; D002214:Capsules / Q000600:supply & distribution; D062787:Drug Overdose / Q000401:mortality*; D011307:Drug Prescriptions / Q000706:statistics & numerical data; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000145:classification / Q000506:poisoning*; D011358:Product Surveillance, Postmarketing; D006113:United Kingdom / Q000453:epidemiology
D014151:Anti-Anxiety Agents; D001463:Barbiturates; D002214:Capsules; D006993:Hypnotics and Sedatives; D001569:Benzodiazepines